Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

703 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Indian Patents Law Indirectly Recognizes ‘Swiss-Type’ Claims’

    Novelty is one of the basic criteria of patentability, inventiveness and industrial applicability being the other two. If the use of a substance or a composition for a specified medical purpose is new, a claim in a patent application directed at this use will be considered as novel even if the same substance had previously been used in medicine for a different purpose.
    IndiaGovernment, Public Sector
    Lex Orbis
    Lex Orbis
  • Article

    Renewed Global Interest In Geographic Diversification Of Supply Chains - Senior Government Officials Spotlight Investment In The US-India Corridor

    Against the backdrop of an estimated USD 200 billion spend on India's healthcare infrastructure by 2022 and with the healthcare industry expected to grow by 17-19% CAGR for the next five years.
    IndiaGovernment, Public Sector
Nexdigm Private Limited
Nexdigm Private Limited
  • Article

    Analysing The Legality And Ethical Debates Surrounding Biological Patents

    In today's day and age, scientific innovations are developing at a break neck speed. A lion's share of this development is facilitated by the biotechnology sector.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Compulsory Licensing Of Patents And Access To Essential Medicines

    A patent is an exclusive right for an invention that could be a product or a process.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    First Vaccine For Zika Virus Developed By Bharat Biotech

    Even though the virus is yet to spread in parts of India, it is imperative for the hoi polloi to be aware of its spread, chiefly for two reasons.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Healthcare | July And August 2024 - Case Laws

    The Supreme Court of India ("Supreme Court"), in the case of Sun Pharmaceutical Industries Ltd. vs. Union of India and Others, has upheld the recovery demand issued by the National Pharmaceutical Pricing Authority...
    IndiaFood, Drugs, Healthcare, Life Sciences
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    TechRx: December 2023

    Arrests made for role in the 2023 leak of COVID-19 data held by Indian Council of Medical Research (ICMR): In October 2023, the ICMR COVID-19 testing database was hacked...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ikigai Law
    Ikigai Law
  • Article

    The Proposed Medical Devices (Amendment) Rules, 2026: A Comprehensive Analysis Of Regulatory Modifications To The Medical Devices Framework

    The Central Government, exercising its rule-making authority under Section 12(1) and Section 33(1) of the Drugs and Cosmetics Act, 1940, has proposed significant amendments to the Medical Devices Rules, 2017...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Delhi High Court Bars Use Of 'Vigoura' To Protect Pfizer's Brand 'Viagra'

    The Delhi High Court, through its judgment in the case of Pfizer Products Inc. v. Renovision Exports Pvt. Ltd. and Anr CS(COMM) 378/2018, dated May 1, 2024, has decreed the suit in favour of the US-based drug major Pfizer Products Inc.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    European Medicines Agency (EMA): Recommends Approval Of Four Medicines In Its December Meeting

    Besremi was designated as an orphan medicinal product on December 09, 2011.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    CCI Approves Of Athenahealth Group Inc. By Minerva Bidco

    On February 7, 2022, CCI approved the acquisition of athenahealth Group Inc. (‘Target') by Minerva Bidco. Inc. (‘Minerva Bidco'), which is indirectly held by funds managed or advised...
    IndiaAntitrust/Competition Law
    AZB & Partners
    AZB & Partners
  • Article

    Covid-19 Vaccination In India

    01 Which are the COVID-19 vaccines that have been currently approved by the Indian Government?
    IndiaCoronavirus (COVID-19)
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Additional Guidelines For Health & Wellness Celebrities And Influencers

    On August 10, 2023, the Department of Consumer Affairs ("DCA") issued additional guidelines for celebrities, influencers, and virtual influencers who endorse health and wellness products or services ("Guidelines").
    IndiaFood, Drugs, Healthcare, Life Sciences
    Spice Route Legal
    Spice Route Legal
  • Article

    Checking The Pulse - Recent Legal Developments In The Indian Healthcare And Pharma Sector - June 1 - July 31, 2024

    As per Rule 161(iv) of GFRs, a GTE is floated when a particular Ministry or Department feels that the goods of required quality, specifications, etc., may not be available in India and finds it
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    DISHA – India's Probable Response To The Law On Protection Of Digital Health Data

    With the outbreak of the COVID-19 pandemic, many developing countries including India are on the cusp of a digital revolution.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Clasis Law
    Clasis Law
  • Article

    EMA Adopts ICH S9 Guideline On Non-Clinical Evaluation Of Anti-Cancer Pharmaceuticals

    On 16 May 2018, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted the ICH S9 guideline on non-clinical evaluation of anti-cancer pharmaceuticals (Step 5) ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Food & Pharma Flash - October 2014

    The government would initially allocate Rs.500 crore between all the pharma funds to be set up under this project.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    India Healthcare Highlights July 2019

    This segment of the newsletter shares recent information associated with regulatory reforms from Healthcare and Pharmaceutical sectors from in Indian jurisdiction.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Osimertinib Granted Breakthrough Designation By FDA For 1st-line Treatment Of Patients With EGFR (Epidermal Growth Factor Receptor) Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)

    Osimertinib targets this secondary mutation that leads to disease progression.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Tax On Freebies To The Doctors

    Reported here are the recent developments in the regulatory landscape of India, that are relevant for the medical professionals as well as the pharmaceutical and allied healthcare industry ("Industry").
    IndiaFood, Drugs, Healthcare, Life Sciences
    LexCounsel
    LexCounsel
  • Showing 261–280 of 703 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics